Deep Breathe receives $1M federal funding for AI diagnostics software

by@CogAbility

Summary

London-based medical software company Deep Breathe has received $1 million in federal funding from the Regional Artificial Intelligence Initiative to further develop its AI-assisted diagnostic ultrasound technology. This innovative software enables quick and user-friendly medical diagnoses in various settings, including ambulances, hospitals, and military operations, addressing urgent health questions about conditions like collapsed lungs or pneumonia. The funding is part of a broader $700 million federal initiative aimed at strengthening AI capabilities in Canada, particularly in health and life sciences, to promote the commercialization of domestic technologies while ensuring companies remain based in the country. The financial support will help Deep Breathe navigate Health Canada regulatory approvals and attract new talent as it advances its technology to more widespread use.

Analysis

Deep Breathe: Deep Breathe is a London, Ontario-based medical software company focused on AI-assisted diagnostic ultrasound technology. The company develops software that integrates with portable ultrasound hardware to enable faster, more accessible medical diagnoses by users with varying levels of expertise. The firm is the direct recipient of the recent federal funding for advancing this technology toward regulatory approvals and further development. Arielle Kayabaga: Arielle Kayabaga is the Member of Parliament for London West in Ontario. She attended the funding announcement and emphasized the technology's value for military personnel and seniors in detecting lung conditions. Her participation highlights ongoing local government engagement with AI advancements in the region. Dr. Rob Arntfield: Dr. Rob Arntfield is the CEO of Deep Breathe, the company behind the AI diagnostics software. He has publicly described the technology's role in addressing common diagnostic questions in everyday and urgent care scenarios. His leadership positions the company at the center of the federal initiative supporting Canadian AI innovation in health applications. Peter Fragiskatos: Peter Fragiskatos is the Member of Parliament for London North Centre in Ontario. He participated in demonstrating the new AI ultrasound technology and noted its potential for frontline military use and improved detection of lung abnormalities. His involvement reflects parliamentary support for regional AI health projects. Regulatory Path: Funding is directed toward securing Health Canada approvals to advance prototype AI medical software into broader deployment. Government Initiative: Canadian federal programs are prioritizing support for AI in health and life sciences to promote commercialization and keep companies domestically based. Healthcare Innovation: AI diagnostic tools are being adapted for portable use in ambulances, hospitals, and military settings to allow quicker assessments by non-specialists.

Categories

aitechmachine_learningpolitics
View Original Tweet